Acenocoumarol
Azathioprine may decrease the anticoagulant activities of Acenocoumarol.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Azathioprine.
Allopurinol
The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.
Advertisement
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Azathioprine.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Azathioprine.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Azathioprine is combined with Anthrax immune globulin human.
Advertisement
Balsalazide
The metabolism of Azathioprine can be decreased when combined with Balsalazide.
BCG Vaccine
The risk or severity of adverse effects can be increased when Azathioprine is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Bacillus calmette-guerin substrain connaught live antigen.
Advertisement
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Bacillus calmette-guerin substrain tice live antigen.
Benazepril
The risk or severity of anemia and severe leukopenia can be increased when Benazepril is combined with Azathioprine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Azathioprine.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Azathioprine.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Azathioprine.
Captopril
The risk or severity of anemia and severe leukopenia can be increased when Captopril is combined with Azathioprine.
Cilazapril
The risk or severity of anemia and severe leukopenia can be increased when Cilazapril is combined with Azathioprine.
Cyclophosphamide
Azathioprine may increase the hepatotoxic activities of Cyclophosphamide.
Cyclophosphamide Anhydrous
Azathioprine may increase the hepatotoxic activities of Cyclophosphamide.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Azathioprine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Azathioprine.
Dicumarol
Azathioprine may decrease the anticoagulant activities of Dicoumarol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Azathioprine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Azathioprine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Azathioprine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Azathioprine.
Enalapril
The risk or severity of anemia and severe leukopenia can be increased when Enalapril is combined with Azathioprine.
Enalaprilat
The risk or severity of anemia and severe leukopenia can be increased when Enalaprilat is combined with Azathioprine.
Enalaprilat Anhydrous
The risk or severity of anemia and severe leukopenia can be increased when Enalaprilat is combined with Azathioprine.
Febuxostat
The serum concentration of Azathioprine can be increased when it is combined with Febuxostat.
Fingolimod
Azathioprine may increase the immunosuppressive activities of Fingolimod.
Fluindione
Azathioprine may decrease the anticoagulant activities of Fluindione.
Fosinopril
The risk or severity of anemia and severe leukopenia can be increased when Fosinopril is combined with Azathioprine.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Azathioprine is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Azathioprine is combined with Hepatitis B Vaccine (Recombinant).
Imidapril
The risk or severity of anemia and severe leukopenia can be increased when Imidapril is combined with Azathioprine.
Leflunomide
The risk or severity of adverse effects can be increased when Azathioprine is combined with Leflunomide.
Lipegfilgrastim
Azathioprine may increase the myelosuppressive activities of Lipegfilgrastim.
Lisinopril
The risk or severity of anemia and severe leukopenia can be increased when Lisinopril is combined with Azathioprine.
Lisinopril Anhydrous
The risk or severity of anemia and severe leukopenia can be increased when Lisinopril is combined with Azathioprine.
Mercaptopurine
Azathioprine may increase the myelosuppressive activities of Mercaptopurine.
MERCAPTOPURINE ANHYDROUS
Azathioprine may increase the myelosuppressive activities of Mercaptopurine.
Mesalamine
The metabolism of Azathioprine can be decreased when combined with Mesalazine.
Moexipril
The risk or severity of anemia and severe leukopenia can be increased when Moexipril is combined with Azathioprine.
Natalizumab
The risk or severity of adverse effects can be increased when Azathioprine is combined with Natalizumab.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Azathioprine.
Olsalazine
The metabolism of Azathioprine can be decreased when combined with Olsalazine.
Ouabain
Ouabain may decrease the cardiotoxic activities of Azathioprine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Azathioprine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Azathioprine.
Perindopril
The risk or severity of anemia and severe leukopenia can be increased when Perindopril is combined with Azathioprine.
Phenindione
Azathioprine may decrease the anticoagulant activities of Phenindione.
Phenprocoumon
Azathioprine may decrease the anticoagulant activities of Phenprocoumon.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Azathioprine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Azathioprine.
Quinapril
The risk or severity of anemia and severe leukopenia can be increased when Quinapril is combined with Azathioprine.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Azathioprine is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Rabies virus inactivated antigen, A.
Ramipril
The risk or severity of anemia and severe leukopenia can be increased when Ramipril is combined with Azathioprine.
Rescinnamine
The risk or severity of anemia and severe leukopenia can be increased when Rescinnamine is combined with Azathioprine.
Ribavirin
The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Ribavirin.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Azathioprine.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Azathioprine is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Azathioprine is combined with Rubella virus vaccine.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Azathioprine is combined with Salmonella typhi ty21a live antigen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Azathioprine.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Azathioprine.
Spirapril
The risk or severity of anemia and severe leukopenia can be increased when Spirapril is combined with Azathioprine.
Sulfamethoxazole
Sulfamethoxazole may increase the myelosuppressive activities of Azathioprine.
Sulfasalazine
The metabolism of Azathioprine can be decreased when combined with Sulfasalazine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Azathioprine.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Azathioprine is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tofacitinib
Azathioprine may increase the immunosuppressive activities of Tofacitinib.
Trandolapril
The risk or severity of anemia and severe leukopenia can be increased when Trandolapril is combined with Azathioprine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Azathioprine.
Trimethoprim
Trimethoprim may increase the myelosuppressive activities of Azathioprine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Azathioprine is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Varicella Zoster Vaccine (Live/Attenuated).
Warfarin
Azathioprine may decrease the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Azathioprine is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Azathioprine is combined with Yellow Fever Vaccine.
Zofenopril
The risk or severity of anemia and severe leukopenia can be increased when Zofenopril is combined with Azathioprine.
